Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT

With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, Elevance Health, Inc. (NYSE:ELV) earns a spot on our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman.

Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT

Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements.

On July 17, 2025, Elevance Health, Inc. (NYSE:ELV) released its Q2 2025 results. The company posted adjusted EPS of $8.84, slightly missing expectations of $8.91. Increased medical cost trends in ACA, along with slower Medicaid rate recovery softening margins. Yet, the higher premium yields and acquisitions resulted in a $49.4 billion revenue, an increase of 14% YoY. Meanwhile, the company’s operating cash flow reached $2.1 billion.

Declines in Medicaid and ACA enrollment resulted in a decrease in the Membership segment, taking it to 45.6 million. Looking ahead, Elevance Health, Inc. (NYSE:ELV) reduced its full-year EPS guidance to $30, driven by cost pressures. However, it reaffirmed its strategies to stabilize margins with disciplined pricing, AI-enabled care management, and Carelon’s expanding value-based and pharmacy services.

Despite the reduction in 2025 guidance, Mizuho maintained its ‘Buy’ rating on Elevance Health, Inc. (NYSE:ELV) with a $342 price target. The analyst’s optimism is driven by the company’s growth potential in Carelon and strong execution in Medicare Advantage.

Elevance Health, Inc. (NYSE:ELV) is a health insurance provider, offering integrated medical, pharmacy, and care delivery solutions. It is included in our list of cheap value stocks to buy.

While we acknowledge the potential of ELV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ELV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks.

Disclosure: None.